LOSS OF INSULIN-RECEPTOR IMMUNOREACTIVITY FROM THE SUBSTANTIA-NIGRA PARS-COMPACTA NEURONS IN PARKINSONS-DISEASE

被引:8
|
作者
MOROO, I
YAMADA, T
MAKINO, H
TOOYAMA, I
MCGEER, PL
MCGEER, EG
HIRAYAMA, K
机构
[1] CHIBA UNIV, SCH MED, DEPT NEUROL, 1-8-1 INOHANA, CHUO KU, CHIBA 260, JAPAN
[2] CHIBA UNIV, SCH MED, DIV INTERNAL MED 2, CHIBA, JAPAN
[3] SHIGA UNIV MED SCI, INST MOLEC NEUROBIOL, OTSU, SHIGA 52021, JAPAN
[4] UNIV BRITISH COLUMBIA, DEPT PSYCHIAT, KINSMEN LAB NEUROL RES, VANCOUVER V6T 1W5, BC, CANADA
[5] UNIV BRITISH COLUMBIA, CTR NEURODEGENERAT DIS, VANCOUVER V6T 1W5, BC, CANADA
关键词
PARKINSONS DISEASE; SUBSTANTIA-NIGRA INSULIN RECEPTOR; IMMUNOCHEMISTRY;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Immunohistochemistry using both a newly developed polyclonal, and a commercially available monoclonal, anti-insulin receptor antibody was done on the midbrain from cases of idiopathic Parkinson's disease (PD), Alzheimer's disease, amyotrophic lateral sclerosis, vascular parkinsonism and non-neurological controls. Both antibodies gave identical patterns of neuronal staining. The neurons of the oculomotor nucleus were immunopositive in all the brains. However, the neurons in the pars compacta of the substantia nigra, paranigral nucleus, parabrachial pigmental nucleus, tegmental pedunculopontine nucleus, supratrocheal nucleus, cuneiform nucleus, subcuneiform nucleus and lemniscus medialis, which were positive in other diseases and in non-neurological controls, were not stained by these antibodies in PD brains. These results suggest that, in PD, a dysfunction of the insulin/insulin receptor system may precede death of the dopaminergic neurons.
引用
收藏
页码:343 / 348
页数:6
相关论文
共 32 条
  • [1] UNALTERED ACONITASE ACTIVITY, BUT DECREASED COMPLEX-I ACTIVITY IN SUBSTANTIA-NIGRA PARS-COMPACTA OF PATIENTS WITH PARKINSONS-DISEASE
    JANETZKY, B
    HAUCK, S
    YOUDIM, MBH
    RIEDERER, P
    JELLINGER, K
    PANTUCEK, F
    ZOCHLING, R
    BOISSL, KW
    REICHMANN, H
    NEUROSCIENCE LETTERS, 1994, 169 (1-2) : 126 - 128
  • [2] NEURONAL HYPERTROPHY IN THE PARS RETICULATA OF THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE
    NEAL, JW
    PEARSON, RCA
    COLE, G
    POWELL, TPS
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1991, 17 (03) : 203 - 206
  • [3] MEAN VOLUME OF PIGMENTED NEURONS IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE
    MOLLER, A
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 85 : 37 - 39
  • [4] IRON HISTOCHEMISTRY OF THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE
    MORRIS, CM
    EDWARDSON, JA
    NEURODEGENERATION, 1994, 3 (04): : 277 - 282
  • [5] IS THE VULNERABILITY OF NEURONS IN THE SUBSTANTIA-NIGRA OF PATIENTS WITH PARKINSONS-DISEASE RELATED TO THEIR NEUROMELANIN CONTENT
    KASTNER, A
    HIRSCH, EC
    LEJEUNE, O
    JAVOYAGID, F
    RASCOL, O
    AGID, Y
    JOURNAL OF NEUROCHEMISTRY, 1992, 59 (03) : 1080 - 1089
  • [6] REDUCED AND OXIDIZED GLUTATHIONE IN THE SUBSTANTIA-NIGRA OF PATIENTS WITH PARKINSONS-DISEASE
    SOFIC, E
    LANGE, KW
    JELLINGER, K
    RIEDERER, P
    NEUROSCIENCE LETTERS, 1992, 142 (02) : 128 - 130
  • [7] SINGLE SECTION AND DISECTOR COUNTS IN EVALUATING NEURONAL LOSS FROM THE SUBSTANTIA-NIGRA IN PATIENTS WITH PARKINSONS-DISEASE
    MA, SY
    ROYTTA, M
    RINNE, JO
    COLLEN, Y
    RINNE, UK
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1995, 21 (04) : 341 - 343
  • [8] PATHOLOGICAL-CHANGES IN DENDRITES OF SUBSTANTIA-NIGRA NEURONS IN PARKINSONS-DISEASE - A GOLGI-STUDY
    PATT, S
    GERTZ, HJ
    GERHARD, L
    CERVOSNAVARRO, J
    HISTOLOGY AND HISTOPATHOLOGY, 1991, 6 (03) : 373 - 380
  • [9] RETENTION OF BASIC FIBROBLAST GROWTH-FACTOR IMMUNOREACTIVITY IN DOPAMINERGIC-NEURONS OF THE SUBSTANTIA-NIGRA DURING NORMAL AGING IN HUMANS CONTRASTS WITH LOSS IN PARKINSONS-DISEASE
    TOOYAMA, I
    MCGEER, EG
    KAWAMATA, T
    KIMURA, H
    MCGEER, PL
    BRAIN RESEARCH, 1994, 656 (01) : 165 - 168
  • [10] NEUROMELANIN-CONTAINING NEURONS OF THE SUBSTANTIA-NIGRA ACCUMULATE IRON AND ALUMINUM IN PARKINSONS-DISEASE - A LAMMA STUDY
    GOOD, PF
    OLANOW, CW
    PERL, DP
    BRAIN RESEARCH, 1992, 593 (02) : 343 - 346